Cargando…

Predicting response/resistance to endocrine therapy for breast cancer

Detalles Bibliográficos
Autores principales:	Miller, WR, Anderson, TJ, Evans, D, Krause, A, Dixon, JM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233477/ http://dx.doi.org/10.1186/bcr1056

Ejemplares similares

Evolution of aromatase inhibitors as an endocrine treatment for breast cancer
por: Miller, WR
Publicado: (2006)

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer
por: Burmi, RS, et al.
Publicado: (2006)

Protein bomarkers Ki67, HOXC10 and HOXC11 for the prediction of response to endocrine treatment in breast cancer
por: Soon, YH, et al.
Publicado: (2015)

Longterm endocrine effects of cancer
por: Zacharin, Margaret
Publicado: (2013)

Biomarkers and predictive factors of response to neoadjuvant treatment
por: Dowsett, M, et al.
Publicado: (2009)

Using magnetic resonance to diagnose breast cancer and predict therapeutic response
por: Nelson, MT
Publicado: (2004)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
por: Klijn, JGM, et al.
Publicado: (2005)

Endocrine dysfunctions in patients with mitochondrial diseases
por: Cho, Ja Hyang, et al.
Publicado: (2015)

Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Endocrine disrupter effects on the gonads and pubertY
por: Söder, Olle
Publicado: (2013)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

Predicting breast cancer behavior by microarray analysis
por: van de Vijver, M
Publicado: (2003)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Growth regulation and steroid hormone resistance in breast cancer
por: Horwitz, KB
Publicado: (2000)

Insulin resistance in breast cancer: relevance and clinical implications
por: Goodwin, PJ
Publicado: (2011)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Targeting the cell cycle for prognosis and therapy of breast cancer
por: Keyomarsi, K, et al.
Publicado: (2005)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Expression profiling as a prognostic and predictive factor in breast cancer
por: van 't Veer, LJ
Publicado: (2005)

Combined hormonal therapy for advanced breast cancer in postmenopausal patients
por: Langecker, P, et al.
Publicado: (2003)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Functional characterization of mammary stem cells in development and breast cancer
por: Rosen, JM, et al.
Publicado: (2003)

Pathology results from the UK Age Trial
por: Ellis, IO, et al.
Publicado: (2004)

Modeling virus exposure during male to female transmission of HIV-1
por: Carias, A, et al.
Publicado: (2012)

4.5: Diagnosing breast cancer in a high-risk cohort
por: O'Flynn, EAM, et al.
Publicado: (2013)

Correlations between shear wave elastography and mammographic findings in invasive breast cancer
por: Budak, MJ, et al.
Publicado: (2011)

Evaluating tumour response to primary radiochemotherapy in breast cancer patients: what role for breast magnetic resonance imaging?
por: Thibault, F, et al.
Publicado: (2008)

Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers
por: Selli, Cigdem, et al.
Publicado: (2016)

Towards an immunoscore for triple negative breast cancer (TNBC): lymphocytic infiltrate predicts outcome
por: Adams, Sylvia, et al.
Publicado: (2013)

OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract
por: Carias, AM, et al.
Publicado: (2009)

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status
por: Flanagan, JM, et al.
Publicado: (2010)

Gamma probe and ultrasound-guided percutaneous localisation of the sentinel lymph node in breast cancer patients
por: Whelehan, P, et al.
Publicado: (2012)

Pharyngeal enlargement via tongue advancement differs with mandibular advancement therapy response and improves treatment prediction
por: Jugé, L, et al.
Publicado: (2021)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Can high-frequency ultrasound predict metastatic lymph nodes in patients with invasive breast cancer?
por: Clough, GR, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_8eu9e579iv5dprke0nrlh4lq71